Soojeong Kang
Overview
Explore the profile of Soojeong Kang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
343
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dhandapany P, Kang S, Kashyap D, Rajagopal R, Sundaresan N, Singh R, et al.
Sci Adv
. 2021 Feb;
7(2).
PMID: 33523960
Hypertrophic cardiomyopathy (HCM) is a heterogeneous genetic heart muscle disease characterized by hypertrophy with preserved or increased ejection fraction in the absence of secondary causes. However, recent studies have demonstrated...
2.
Kim E, Koo B, Kim S, Huh K, Kang S, Choi Y
Yonsei Med J
. 2019 Feb;
60(3):291-297.
PMID: 30799592
Purpose: Cardiac changes in end-stage renal disease are the most common causes of death after kidney transplantation (KT). Chronic kidney disease presents a major risk factor for the development and...
3.
Lee B, Park W, Yun S, Kang S, Kim H
J Int Med Res
. 2018 Dec;
47(1):235-243.
PMID: 30556457
Objective: Nasotracheal (NT) intubation is commonly applied during head and neck surgery. However, improper tube size and depth may cause complications. In the current study, we investigated whether NT tubes...
4.
Kim E, Chang S, Kim S, Huh K, Kang S, Choi Y
Int J Med Sci
. 2016 Aug;
13(8):620-8.
PMID: 27499694
Patients with end-stage renal disease (ESRD) show characteristic abnormalities in cardiac structure and function. We evaluated the influence of these abnormalities on adverse cardiopulmonary outcomes after living donor kidney transplantation...
5.
Kang S, Dahl R, Hsieh W, Shin A, Zsebo K, Buettner C, et al.
J Biol Chem
. 2015 Dec;
291(10):5185-98.
PMID: 26702054
Dysregulation of endoplasmic reticulum (ER) Ca(2+) homeostasis triggers ER stress leading to the development of insulin resistance in obesity and diabetes. Impaired function of the sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA) has...
6.
Chemaly E, Kang S, Zhang S, McCollum L, Chen J, Benard L, et al.
J Physiol
. 2013 Sep;
591(21):5337-55.
PMID: 24018949
Pathological left ventricle (LV) hypertrophy (LVH) results in reactive and replacement fibrosis. Volume overload LVH (VOH) is less profibrotic than pressure overload LVH (POH). Studies attribute subendocardial fibrosis in POH...
7.
Karakikes I, Chaanine A, Kang S, Mukete B, Jeong D, Zhang S, et al.
J Am Heart Assoc
. 2013 Apr;
2(2):e000078.
PMID: 23612897
Background: MicroRNAs (miRNAs) play a key role in the development of heart failure, and recent studies have shown that the muscle-specific miR-1 is a key regulator of cardiac hypertrophy. We...
8.
Park M, Han Y, Kim M, Seo E, Kang S, Park S, et al.
Korean J Physiol Pharmacol
. 2012 Jul;
16(3):181-6.
PMID: 22802699
Fenofibrate is a selective peroxisome proliferator-activated receptor α (PPARα) activator and is prescribed to treat hyperlipidemia. The mechanism through which PPARα agonists reduce food intake, body weight, and adiposity remains...
9.
Kang S, Chemaly E, Hajjar R, Lebeche D
J Biol Chem
. 2011 Apr;
286(21):18465-73.
PMID: 21478152
Resistin has been suggested to be involved in the development of diabetes and insulin resistance. We recently reported that resistin is expressed in diabetic hearts and promotes cardiac hypertrophy; however,...
10.
Kang S, Park E, Joe Y, Seo E, Park M, Seo S, et al.
Endocrinology
. 2010 Nov;
151(12):5638-46.
PMID: 21047948
Recent studies have demonstrated that TNF-related apoptosis-inducing ligand (TRAIL) is a modulator of the immune response. The relation between TRAIL and type 1 diabetes (T1D) as an autoimmune inflammatory disease...